Blockchain Press Releases
Flow Cytometry Market worth $7.0 billion | MarketsandMarkets
CHICAGO, Aug. 9, 2023 /PRNewswire/ — In the near future, the flow cytometry industry is poised to undergo remarkable advancements, driven by ongoing innovations in technology and its widening applications across various fields. With the integration of artificial intelligence and machine learning, data analysis and interpretation will become more efficient and accurate, enabling researchers and clinicians to gain deeper insights from complex cellular data. The miniaturization of flow cytometry instruments will lead to portable and point-of-care devices, revolutionizing diagnostics and personalized medicine. Additionally, the incorporation of multi-parameter analysis and higher-throughput capabilities will enhance the speed and comprehensiveness of cellular profiling. As the industry continues to evolve, collaborations between academia, industry, and healthcare will play a pivotal role in shaping the future of flow cytometry, unlocking its potential to uncover novel discoveries and improve patient outcomes.
Flow Cytometry Market in terms of revenue was estimated to be worth $4.7 billion in 2023 and is poised to reach $7.0 billion by 2028, growing at a CAGR of 8.3% from 2023 to 2028 according to a new report by MarketsandMarkets™.
The growth of this market is driven by the increasing prevalence of chronic diseases and increasing funding for research. Moreover, the launch of novel products in the market by key market players and increased use of flow cytometry in clinical research & diagnostics, such as HIV/AIDS Monitoring, organ transplantation, and cancer diagnostics, are some of the elements propelling the growth of the market.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584
Browse in-depth TOC on “Flow Cytometry Market”
477 – Tables
47 – Figures
416 – Pages
Flow Cytometry Market Scope:
|
Report Coverage |
Details |
|
Market Revenue in 2023 |
$4.7 billion |
|
Estimated Value by 2028 |
$7.0 billion |
|
Growth Rate |
Poised to grow at a CAGR of 8.3% |
|
Market Size Available for |
2021–2028 |
|
Forecast Period |
2023–2028 |
|
Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Technology, Product & Service, Application & End User |
|
Geographies Covered |
North America, Europe, Asia Pacific, Latin America (LATAM), and Middle East and Africa (MEA) |
|
Report Highlights |
Updated financial information / product portfolio of players |
|
Key Market Opportunities |
Public-private funding initiatives in stem cell research |
|
Key Market Drivers |
Technological advancements in flow cytometry instruments |
The Reagents & consumables segment accounted for the largest share of the product & service segment in the flow cytometry market in 2022.
Based on products & services, the flow cytometry market is segmented into software, services, reagents & consumables, instruments, and accessories. Reagents & consumables accounted for the largest share of the flow cytometry market in 2022. The factors attributable to the growth, development of high-quality reagents, increased research activities, and launch of application-specific cytometry reagents.
The Research application segment accounted for the largest share of the application segment in the flow cytometry market in 2022.
Based on applications, the flow cytometry market is segmented into clinical, research and industrial applications. In 2022, the research applications segment accounted for the dominant share in the global flow cytometry market. The dominance of the market is attributable to various factors, such as increased research activities & funding and a rise in industrial & academic collaboration. The clinical applications segment is likely to grow at a significant CAGR owing to the increased adoption of flow cytometry in clinical applications.
North America dominated the flow cytometry market in 2022.
Based on region, the flow cytometry market is segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. In 2022, North America dominated the market, followed by Europe. The presence of key market players in the region and increasing public-private initiatives for research activities are key factors supporting the growth of the North American flow cytometry market. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. The high prevalence of HIV/AIDS & cancer and rising treatment options for target diseases (cancer and immunological disorders) are driving the market growth. Further factors like rising government funding and the strong presence of key players in the region are some of the factors anticipated to contribute to the flow cytometry market growth in the Asia Pacific.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584
Flow Cytometry Market Dynamics:
Drivers:
- Rising incidence of HIV/AIDS and cancer
- Wide applications in research for drug discovery & development
- Use of flow cytometry in regenerative medicine
- Growing public-private initiatives in immunology and immuno-oncology research
- Technological advancements in flow cytometry instruments
Restraints:
- High product pricing
Opportunities:
- High growth potential in emerging economies
- Rising focus on stem cell research
- Uptake of recombinant DNA technology for antibody production
Challenges:
- Complexities related to reagent development
- Shortage of skilled professionals
Key Market Players:
Key players in the flow cytometry market include BD (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Sony Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMérieux (France), Cytonome/ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences (US), Union Biometrica, Inc. (US), Luminex Corporation (Italy), Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), (US), Nexcelom Biosciences LLC. (US), BennuBio Inc. (US), Orflo Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands).
Recent Developments:
- In June 2023, BD launched The BD FACSDuet Premium Sample Preparation System to automate sample preparation in clinical flow cytometry diagnostics.
- In May 2023, Sysmex launched Clinical Flow Cytometry System Flow Cytometer XF-1600, Sample Preparation System PS-10, antibody reagents, and other related products in Japan.
- In June 2022, BD (US) launched BD FACSDiscover S8 Cell Sorter with high-speed imaging technology that sorts cells based on visual characteristics.
- In March 2022, Beckman Coulter, Inc. (US) launched a fully automated sample preparation system (SPS) CellMek SPS, which offers on-demand processing for many sample types to help laboratories expand their capabilities.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=65374584
Flow Cytometry Market Advantages:
- Multiparameter Analysis: Flow cytometry enables simultaneous analysis of multiple cellular parameters (e.g., size, shape, markers), offering a comprehensive view of complex cell populations and their interactions.
- Single-Cell Resolution: The technology provides insights into individual cells, allowing researchers to study heterogeneity, identify rare cell populations, and understand cellular behavior at a granular level.
- High Throughput: Flow cytometers can analyze thousands of cells per second, facilitating rapid data acquisition and significantly reducing experiment duration.
- Automation and Reproducibility: Integration of automation and robotics ensures consistent and reproducible results, minimizing experimental variations and human errors.
- Cell Sorting: Flow cytometers equipped with cell sorting capabilities enable isolation of specific cell subsets for downstream analysis, transplantation, or further experimentation.
- Functional Analysis: Flow cytometry can assess cellular functions, such as viability, proliferation, apoptosis, and cell cycle progression, providing insights into cell health and behavior.
- Immunophenotyping: Valuable in immunology research, flow cytometry helps characterize immune cell populations, aiding in the understanding of immune responses, diseases, and therapies.
- Drug Discovery: Flow cytometry plays a pivotal role in drug development by assessing drug effects on cells, identifying potential drug candidates, and evaluating drug toxicity.
- Cancer Research: It aids in cancer diagnostics and research by detecting cancer cells, characterizing tumor heterogeneity, and evaluating treatment responses.
- Personalized Medicine: Flow cytometry contributes to personalized medicine by enabling tailored treatments based on individual patient profiles and disease characteristics.
- Advanced Data Analysis: Integration with AI and machine learning enhances data interpretation, uncovering complex patterns and relationships within datasets.
- Portable Systems: Miniaturization of instruments results in portable flow cytometry devices suitable for point-of-care diagnostics, field research, and resource-limited settings.
- Clinical Applications: It’s used in clinical laboratories for diagnosing immunological disorders, monitoring disease progression, and assessing treatment efficacy.
- Research Versatility: Flow cytometry finds applications in various fields, including immunology, hematology, microbiology, neuroscience, stem cell research, and more.
- Collaborative Potential: The technology encourages collaboration between researchers, clinicians, and industries, fostering cross-disciplinary advancements.
These pointers highlight the multifaceted advantages of flow cytometry, making it an indispensable tool in scientific research, clinical diagnostics, and healthcare innovation.
Related Reports:
Cell Analysis Market – Global Forecasts to 2028
Single Cell Analysis Market – Global Forecasts to 2028
Stem Cell Assay Market – Global Forecasts to 2027
Esoteric Testing Market – Global Forecasts to 2026
Sepsis Diagnostics Market – Global Forecasts to 2026
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/flow-cytometry-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/flow-cytometry.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/flow-cytometry-market-worth-7-0-billion–marketsandmarkets-301896791.html
SHANGHAI, March 18, 2025 /PRNewswire/ — Cango Inc. (NYSE: CANG) (“Cango” or the “Company”), a leading Bitcoin mining company with an automotive transaction service in China, today announced that it has been included in the Bitwise Bitcoin Standard Corporations ETF (NYSE Arca: OWNB), launched by Bitwise Asset Management on March 11, 2025. The exchange-traded fund (ETF) tracks the Bitwise Bitcoin Standard Index, providing investors with exposure to forward-looking publicly traded corporations holding a minimum of 1,000 Bitcoins on their balance sheets.
“We are proud to be included in the recently launched Bitwise Bitcoin Standard Corporations ETF. Our inclusion highlights the industry’s acknowledgement of our strategic pivot to Bitcoin mining and significant achievements in such a short time,” said Mr. Jiayuan Lin, Chief Executive Officer of Cango. “As a forward-looking company, our future-ready business model ensures we are well-positioned for sustained growth, global expansion, and operational flexibility in the Bitcoin mining sector in 2025 and beyond.”
Since transitioning to a capital-light Bitcoin mining model in Q4 2024, Cango has achieved a number of milestones, including leading the industry in productivity per hash rate with 17.81 Bitcoin per EH/s and securing a hashrate of 32 EH/s, ranking 3rd globally.
About Cango Inc.
Cango Inc. (NYSE: CANG) primarily operates a leading Bitcoin mining business. Headquartered in Shanghai, China, Cango has deployed its mining operation across strategic locations including North America, Middle East, South America, and East Africa. Cango expanded into the crypto assets market in November 2024, driven by the development in blockchain technology, increasing prevalence of crypto assets and its endeavor to diversify its business. Meanwhile, Cango has continued to operate the automotive transaction service in China since 2010, aiming to make car purchases simple and enjoyable. For more information, please visit: www.cangoonline.com.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Cango may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Cango’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Cango’s goal and strategies; Cango’s expansion plans; Cango’s future business development, financial condition and results of operations; Cango’s expectations regarding demand for, and market acceptance of, its solutions and services; Cango’s expectations regarding keeping and strengthening its relationships with dealers, financial institutions, car buyers and other platform participants; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in Cango’s filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and Cango does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Investor Relations Contact
Yihe Liu
Cango Inc.
Tel: +86 21 3183 5088 ext.5581
Email: [email protected]
Helen Wu
Piacente Financial Communications
Tel: +86 10 6508 0677
Email: [email protected]
View original content:https://www.prnewswire.co.uk/news-releases/cango-inc-joins-bitwise-bitcoin-standard-corporations-etf-302404481.html
Blockchain Press Releases
BingX Levels Up Trading Experience with CScalp’s Advanced Features & Fee Discounts
PANAMA CITY, Panama, March 18, 2025 /PRNewswire/ — BingX, a global leading cryptocurrency exchange, is excited to announce its integration with CScalp, a free and powerful trading terminal designed for active cryptocurrency and futures traders. This partnership aims to provide BingX users with advanced trading tools and a seamless trading experience across multiple exchanges.
CScalp is renowned for its robust features tailored for scalping and intraday trading. The platform allows traders to operate across multiple exchanges and trade different instruments within a single interface. Its user-friendly interface and comprehensive tools are optimized for quick market analysis, one-click order placement, and efficient position management.
With this integration, BingX users can now leverage CScalp’s capabilities to enhance their trading strategies. The platform’s features, such as multi-account management, stable connection, and customizable workspace, will enable users to execute trades more efficiently and effectively. BingX users can also benefit from discounts on exchange fees, access to trading signals, and an active trader community, fostering a more informed and cost-effective trading experience.
“We are thrilled to integrate BingX with CScalp, providing our users with a powerful tool to enhance their trading experience”, said Vivien Lin, Chief Product Officer of BingX. “This collaboration underscores our commitment to offering innovative solutions that cater to the diverse needs of our trading community.”
This integration not only benefits individual traders but also strengthens BingX’s position in the market by offering a more versatile and user-centric platform. By aligning with CScalp, BingX continues to demonstrate its dedication to providing cutting-edge tools and services that empower its users to navigate the dynamic cryptocurrency trading landscape with confidence.
About BingX
Founded in 2018, BingX is a leading crypto exchange, serving over 20 million users worldwide. BingX offers diversified products and services, including spot, derivatives, copy trading, and asset management – all designed for the evolving needs of users, from beginners to professionals. BingX is committed to providing a trustworthy platform that empowers users with innovative tools and features to elevate their trading proficiency. In 2024, BingX proudly became the official crypto exchange partner of Chelsea Football Club, marking an exciting debut in the world of sports.
For more information please visit: https://bingx.com/
Photo – https://mma.prnewswire.com/media/2644058/BingX_Levels_Up_Trading_Experience_CScalp_s_Advanced_Features___Fee.jpg
Logo – https://mma.prnewswire.com/media/2310183/BingX_logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/bingx-levels-up-trading-experience-with-cscalps-advanced-features–fee-discounts-302404412.html
Blockchain Press Releases
HTX Ventures: Striking a Balance between Compliance and Innovation in a Shifting Regulatory Landscape
SINGAPORE, March 18, 2025 /PRNewswire/ — HTX, a leading crypto exchange, has been ranked as the “Top 3 Exchanges for EUR-Stablecoin Trading Activity” in a recent CoinDesk report titled “MiCAR: The Institutional Playbook for Europe’s Digital Asset Market“. The report explores key trends shaping the European digital asset market with the implementation of Markets in Crypto-Assets Regulation (MiCAR) and highlights that HTX achieved a monthly average EUR-stablecoin trading volume of €48 million, with a notable volume of €33 million in November 2024, ranking third following Binance and Coinbase.
This surge in EUR-denominated trading coincides with the regulatory shifts. Regulatory clarity has become a key driver of institutional adoption and market confidence. The full rollout of MiCAR represents a major milestone for the industry, offering a unified framework that spans across 27 European Union (EU) member states. While MiCAR streamlines compliance and fosters innovation, it also brings along complex challenges that exchanges must navigate. HTX Ventures explores both the opportunities and hurdles that come with this landmark regulation.
Alec Goh, Head of HTX Ventures, said, “The implementation of MiCAR is a major step in the right direction for the crypto industry, providing much-needed regulatory clarity and fostering an environment conducive to institutional adoption. As jurisdictions worldwide become more crypto-friendly, a united framework like MiCAR will accelerate innovation while ensuring robust compliance. At HTX Ventures, we see this as an opportunity to drive the development of on-chain compliance tools, support the emergence of compliant DeFi solutions, and bridge the gap between traditional finance and digital assets.”
Opportunities:
- Unified Regulatory Framework Reduces Costs and Boosts Market Confidence
MiCAR covers all 27 EU member states through a “single license” approach, enabling exchanges to significantly reduce compliance costs across borders. This unified regulatory framework provides a clear and stable regulatory environment for the market, increasing confidence and participation among institutional investors while positioning Europe to becoming the world’s largest compliant digital asset market. - Technological Innovations Drive On-Chain Compliance Tools
To meet MiCAR’s stringent anti-money laundering (AML) and reserve monitoring requirements, exchanges can actively explore compliance tool innovations, including:- Using oracle networks to modularize AML rules and reserve monitoring, executing them on-chain for real-time data transparency.
- Adopting zk-SNARKs to build an on-chain central platform for regulatory data, enabling transaction data desensitization to balance regulatory transparency with user privacy.
- Leveraging account abstraction technology (ERC-4337) to integrate KYC processes into non-custodial wallets, lowering barriers for traditional financial institutions to access DeFi.
- New Opportunities for the Convergence of Traditional and Crypto Assets
With platforms such as Coinbase launching securitized tokens, exchanges can introduce real-world asset (RWA) trading. This includes income-based stablecoins backed by US stocks or Treasuries, enabling users to leverage assets like USDT for multi-asset allocation and global liquidity matching.
Challenges:
- High Costs and Technical Complexity of Compliance
MiCAR imposes strict requirements on stablecoin issuers and Crypto Asset Service Providers (CASPs), including adequate reserves, regular audits, and robust anti-money laundering measures. Exchanges must invest significantly in R&D to integrate compliance tools, data desensitization techniques, and on-chain regulatory platforms without compromising market fluidity.
- Uncertainty in the Dynamic Policy Environment
With regulatory policies evolving rapidly, exchanges must establish multi-chain testing environments and collaborate with regulatory-friendly regions (e.g., Lithuania, Malta) for cross-border stress tests and regulatory scenario simulations. This requires continuous investment, with risks at the policy interpretation and implementation levels.
- Security Risks and Stringent Custody Requirements
Following high-profile incidents like FTX, MiCAR has introduced rigorous digital asset custody requirements, mandating bank-level security measures to prevent hacking and asset loss. As DeFi integrates with traditional financial regulations, exchanges must address both technical vulnerabilities and evolving security risks.
HTX Ventures firmly believes that under a clearer regulatory framework such as MiCAR, exchanges can achieve a win-win situation through technological innovations and global asset allocation, balancing compliance with market innovation. Moving forward, the firm will continue to leverage its insights and expertise to actively explore on-chain compliance tools, expand RWA trading, and build a dynamic testing environment, navigating regulatory complexities and ensuring that crypto innovation remains aligned with long-term institutional adoption and market sustainability.
– End –
About HTX Ventures
HTX Ventures, the global investment division of HTX, integrates investment, incubation, and research to identify the best and brightest teams worldwide. With more than a decade-long history as an industry pioneer, HTX Ventures excels at identifying cutting-edge technologies and emerging business models within the sector. To foster growth within the blockchain ecosystem, we provide comprehensive support to projects, including financing, resources, and strategic advice.
HTX Ventures currently backs over 300 projects spanning multiple blockchain sectors, with select high-quality initiatives already trading on the HTX exchange. Furthermore, as one of the most active FOF (Fund of Funds) funds, HTX Ventures invests in 30 top global funds and collaborates with leading blockchain funds such as Polychain, Dragonfly, Bankless, Gitcoin, Figment, Nomad, Animoca, and Hack VC to jointly build a blockchain ecosystem. Visit us here.
Feel free to contact us for investment and collaboration at [email protected].
About HTX
Founded in 2013, HTX has evolved from a virtual asset exchange into a comprehensive ecosystem of blockchain businesses that span digital asset trading, financial derivatives, wallets, research, investments, incubation, and other businesses. As a world-leading gateway to Web3, HTX harbors global capabilities that enable it to provide users with safe and reliable services. Adhering to the growth strategy of “Global Expansion, Thriving Ecosystem, Wealth Effect, Security & Compliance”, HTX is dedicated to providing quality services and values to virtual asset enthusiasts worldwide.
For more information on HTX, please visit the HTX Square, or https://www.htx.com/, and follow X, Telegram, Discord. For further press enquiries, please contact [email protected].
View original content:https://www.prnewswire.co.uk/news-releases/htx-ventures-striking-a-balance-between-compliance-and-innovation-in-a-shifting-regulatory-landscape-302404319.html
-
Blockchain5 days agoBlocks & Headlines: Today in Blockchain – March 13, 2025: Featuring XRPTurbo, Ripple, DFSA, 75th USARIC, Allianz
-
Blockchain Press Releases4 days agoMEXC Lists AO (AO), Expanding Support for Decentralized Computing and AI Innovation with a 140,000 USDT Prize Pool
-
Blockchain6 days ago
Blocks & Headlines: Today in Blockchain – March 12, 2025 | Blockchain Week Rome, Sony Integration, DC Blockchain Summit, Base, BingX
-
Blockchain Press Releases6 days agoAB DAO Accelerates Global Expansion: Now AB Listed on BitMart & HTX AMA to Explore the Future of Web3
-
Blockchain4 days ago
Concerned Stockholders Prevail in Delaware Court; Obtain Stockholder List Necessary for Robust Proxy Solicitation
-
Blockchain7 days ago
Blocks & Headlines: Today in Blockchain – March 11, 2025: Utah Legislature, Pakistan, Women Leaders, JPMorgan, XRPTurbo, Ripple XRP
-
Blockchain6 days ago
Mercurity Fintech Holding Inc. Announces Strategic Engagement with BitGo for Institutional-Grade Custody Services
-
Blockchain Press Releases5 days ago
HTX Ventures: DeepSeek Triggers AI’s “iPhone Moment”, Accelerating AI Agents into Real Crypto Use
